Short answer
ACCENDRA HEALTH INC/VA/ (ACH) filed an 8-K current report with the SEC on August 17, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Standard Regulation FD disclaimer limiting Securities Exchange Act Section 18 liability.
ACCENDRA HEALTH INC/VA/ 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Standard Regulation FD disclaimer limiting Securities Exchange Act Section 18 liability
- Exhibit content not incorporated into Securities Act filings unless expressly referenced
Item EX-99.1 · Exhibit EX-99.1
- ATM equity program canceled, eliminating planned opportunistic issuance for debt reduction and avoiding potential shareholder dilution
- $300 million revolver undrawn at second-quarter end, supporting management’s stated liquidity confidence
- Two non-core asset sales expected to generate approximately $45 million across Q3 and Q4 with de minimis Adjusted EBITDA impact
- CEO successor expected by mid-September 2026 ahead of Mr. Pesicka’s planned year-end retirement
- Mr. Pesicka to remain CEO until transition and provide advisory support afterward, reducing handoff disruption risk
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ACCENDRA HEALTH INC/VA/ 8-K filings
Get the next ACH 8-K as it lands
Follow ACH for push alerts, or ask the research agent what this filing means.